Literature DB >> 23736105

A review of warfarin dosing with concurrent acetaminophen therapy.

G Michelle Pinson1, Jennifer W Beall, Jeffrey A Kyle.   

Abstract

Warfarin is frequently used for the prevention and treatment of thromboembolism, yet it is associated with numerous drug interactions. Regarding over-the-counter pain medications, the preferred analgesic for those patients who are taking warfarin is acetaminophen. There are, however, reports of elevation in the international normalized ratio (INR) in those patients taking concurrent warfarin and acetaminophen. For those practitioners who manage warfarin therapy, there is little guidance regarding management of the drug-drug interaction between warfarin and acetaminophen. This review seeks to evaluate the drug interaction between warfarin and acetaminophen and provides recommendations for concurrent use of these drugs.

Entities:  

Keywords:  acetaminophen; interaction; warfarin

Mesh:

Substances:

Year:  2013        PMID: 23736105     DOI: 10.1177/0897190013488802

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  4 in total

Review 1.  Palliative Care in Heart Failure.

Authors:  Abhinav Sood; Krista Dobbie; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-19

2.  Acetaminophen in children: an old drug with new warnings.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-10       Impact factor: 3.275

Review 3.  COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.

Authors:  Sergio Pandolfi; Luigi Valdenassi; Geir Bjørklund; Salvatore Chirumbolo; Roman Lysiuk; Larysa Lenchyk; Monica Daniela Doşa; Serafino Fazio
Journal:  Int J Environ Res Public Health       Date:  2022-04-02       Impact factor: 3.390

4.  A descriptive study of pain treatment and its follow-up in primary care of elderly patients after orthopaedic care.

Authors:  Gabriella Caleres; Patrik Midlöv; Åsa Bondesson; Sara Modig
Journal:  J Pharm Health Care Sci       Date:  2020-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.